Advertisements

TherapeuticsMD Inc. (TXMD) Stock Quote

Detailed Quote for TherapeuticsMD Inc. (TXMD)
$ 6.05   0.06 (+1.00%) Volume: 1.95m 4:00 PM EST Nov 22, 2017
After Hours:  $ 5.90   -0.15 (-2.48%) Volume: 8.58k 7:13 PM EST Nov 22, 2017
Today 5d 1m 3m 1y more
Last Price
6.05
Change $
0.06
Change %
1.00%
Tick
  
Bid
5.85
Bid Size
2,800
Ask
6.66
Ask Size
1,000
Open
6.00
High
6.10
Low
5.94
Prev Close
5.99
Last Trade
11/22/17
Volume
1.95m
52 Wk Hi
8.29520034
52 Wk Low
3.50
Market Cap
1.31b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
216,429,642
EPS (TTM)
-0.400000005
PE Ratio
N/A
Exchange
NGS
News and Media for TherapeuticsMD Inc. (TXMD)
Sector News | Topic News
News for TherapeuticsMD Inc. (TXMD)
Wed, Nov 22, 2017
5:36 PM After Hours Gainers / Losers - SeekingAlpha
Tue, Nov 07, 2017
4:30 PM TherapeuticsMD to Present at Two Upcoming Investor Conferences - Business Wire
12:01 PM Your Daily Pharma Scoop: Anxious Time For Dynavax Longs, VBL Therapeutics Gets A Boost, Roche Gets 2 FDA Approvals - SeekingAlpha
8:10 AM Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TherapeuticsMD - ACCESSWIRE IA
4:27 AM TherapeuticsMD Gets Lift From FDA Leniency - SeekingAlpha
Mon, Nov 06, 2017
3:45 PM Biotech Forum Daily Digest: Why Adamas Is Soaring - SeekingAlpha
2:18 PM TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2017 Results - Earnings Call Transcript - SeekingAlpha
1:07 PM Midday Gainers / Losers - SeekingAlpha
9:28 AM Premarket Gainers as of 9:05 am - SeekingAlpha
7:08 AM TherapeuticsMD on go with resubmission of TX-004HR NDA without new pre-approval study; shares ahead 50% premarket - SeekingAlpha
6:37 AM TherapeuticsMD net loss improves in Q3; shares up 47% premarket - SeekingAlpha
6:07 AM TherapeuticsMD beats by $0.04, misses on revenue - SeekingAlpha
6:05 AM TherapeuticsMD Announces Third Quarter 2017 Financial Results - Business Wire
6:00 AM TherapeuticsMD Announces Plan to Resubmit the New Drug Application for TX-004HR - Business Wire
Sun, Nov 05, 2017
5:30 PM Notable earnings before Monday's open - SeekingAlpha
Fri, Nov 03, 2017
4:21 PM TherapeuticsMD to release Q3 results and update investors on TX-004HR on Monday - SeekingAlpha
4:05 PM TherapeuticsMD to Host TX-004HR Regulatory Update and Third Quarter Financial Results Conference Call and Webcast on November 6 - Business Wire
2:57 AM TherapeuticsMD: Big Day Friday - SeekingAlpha
Fri, Oct 27, 2017
8:30 AM Research Report Identifies Campbell Soup, Hormel Foods, Southwest Airlines, TherapeuticsMD, Goodyear Tire, and General Mills with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement - GlobeNewswire
Thu, Oct 26, 2017
8:05 AM TherapeuticsMD: Near Term Catalysts and Analysts Review - ACCESSWIRE IA
More News for TXMD >>

Tags for TherapeuticsMD Inc.

Research stocks or mutual funds related to TherapeuticsMD Inc. by keywords or tags. Find companies that have a similar focus to TXMD. The keywords below have been associated to TXMD by either user submission or electronic means.